TRANSPLANT Act of 2021
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Apr 15, 2021 | House · vote #109 | On Motion to Suspend the Rules and Pass | Passed | 415–2 | See who voted → |
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021
This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.
The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.
In addition, the Government Accountability Office must report on the regenerative medicine workforce.
Became Public Law No: 117-15.
- Engrossed in House Formatted Text PDF Formatted XML
- Enrolled Bill Formatted Text PDF Formatted XML
- Introduced in House Formatted Text PDF Formatted XML
- Public Law Formatted Text PDF United States Legislative Markup
- Referred in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 941: TRANSPLANT Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-941/
"H.R. 941: TRANSPLANT Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-941/.
H.R. 941, 117th Cong. (2026), https://openamerica.io/bill/117-HR-941/.
[H.R. 941: TRANSPLANT Act of 2021](https://openamerica.io/bill/117-HR-941/)